Clinical outcome of primary giant cell tumor of bone after curettage with or without perioperative denosumab in Japan: from a questionnaire for JCOG 1610 study

Hiroshi Urakawa(Nagoya University Hospital), Toshifumi Ozaki(Okayama University), Kenji Satô(Albert Einstein College of Medicine), Akira Takemoto(Yokohama City University), Toshiyuki Kunisada(Okayama University Hospital), Toshihiro Akisue(Kobe University), Akihito Nagano(Gifu University), Kazuhiro Tanaka(Oita University), Makoto Emori, Kunihiro Asanuma(Mie University), Satoshi Tsukushi(Aichi Cancer Center), Yoshihiro Nishida(Nagoya University), Koji Hatano(Niigata Cancer Center Hospital), Akira Kawai(GTx (United States)), Koji Hiraoka, Tatsuya Takagi(Juntendo University), Munenori Watanuki(Tohoku University Hospital), Hiroaki Hiraga, Tsukasa Yonemoto, Seiichi Matsumoto, Yoshihiro Matsumoto(Jikei University Kashiwa hospital), Hideki Yoshikawa(Amita Health), Takeshi Morii(Kyorin University), Masanori Kawano(Oita University), Norifumi Naka(University of the Witwatersrand), Mitsuru Takahashi(Shizuoka Cancer Center), Tadahiko Kubo(Hiroshima University), Yukihide Iwamoto(Kyushu University)
World Journal of Surgical Oncology
August 8, 2018
Cited by 55


Related Papers